16:34 EDT Regenxbio files to sell 257,466 shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RGNX:
- Regenxbio seescash, cash equivalents, securities sufficient into 2025
- Regenxbio reports Q2 EPS ($1.66), consensus ($1.38)
- REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
- Regenxbio to hold a virtual investor day
- Regenxbio provides update on interim results of retinal and Duchenne programs